Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.21% | 149.48 | 0.7% | $741.20m | |
| BMY | Bristol-Myers Squibb Co. | 1.06% | 67.43 | 1.0% | $732.45m | |
| PFE | Pfizer Inc. | -0.40% | 40.35 | 0.9% | $572.52m | |
| MRK | Merck & Co., Inc. | -1.11% | 89.96 | 0.7% | $567.99m | |
| ABBV | AbbVie, Inc. | 0.00% | 88.00 | 2.3% | $549.02m | |
| LLY | Eli Lilly & Co. | 0.96% | 140.92 | 1.1% | $394.62m | |
| APLS | Apellis Pharmaceuticals, Inc. | 6.27% | 43.04 | 0.0% | $117.42m | |
| NVS | Novartis AG | -0.78% | 95.19 | 0.2% | $109.87m | |
| AZN | AstraZeneca Plc | -1.04% | 50.80 | 1.2% | $95.45m | |
| GSK | GlaxoSmithKline Plc | -0.81% | 47.50 | 0.2% | $89.73m | |
| KRTX | Karuna Therapeutics, Inc. | 4.57% | 109.30 | 0.0% | $65.08m | |
| NVO | Novo Nordisk A/S | -0.26% | 61.15 | 0.1% | $64.59m | |
| RETA | Reata Pharmaceuticals, Inc. | 0.71% | 212.93 | 3.5% | $64.21m | |
| SNY | Sanofi | -2.01% | 50.21 | 0.2% | $58.92m | |
| RARX | Ra Pharmaceuticals, Inc. | -0.23% | 46.86 | 0.8% | $36.84m |
Company Profile
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.